Impact of robotic antineoplastic preparation on safety, workflow, and costs

Journal of Oncology Practice

Volumn 8, Issue 6, 2012, Pages 344-349

  Seger, Andrew C ^a   Churchill, William W ^a   Keohane, Carol A ^a   Belisle, Caryn D ^a   Wong, Stephanie T ^a   Sylvester, Katelyn W ^a   Chesnick, Megan A ^a   Burdick, Elisabeth ^a   Wien, Matt F ^a   Cotugno, Michael C ^a   Bates, David W ^a   Rothschild, Jeffrey M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; DRUG COST; DRUG SAFETY; DRUG SYNTHESIS; GRAVIMETRY; HOSPITAL PHARMACY; HUMAN; MANUAL LABOR; MEASUREMENT ACCURACY; MEDICAL STAFF; MEDICATION ERROR; OUTCOMES RESEARCH; PATIENT SAFETY; PHARMACIST; PHARMACY TECHNICIAN; PRODUCTIVITY; ROBOTICS; TIME; UNIVERSITY HOSPITAL; WORKFLOW;

ACADEMIC MEDICAL CENTERS; ANTINEOPLASTIC AGENTS; COSTS AND COST ANALYSIS; DRUG COMPOUNDING; HUMANS; MASSACHUSETTS; MEDICATION ERRORS; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACY SERVICE, HOSPITAL; ROBOTICS; SAFETY MANAGEMENT; WORKFLOW;

EID: 84875949170     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2012.000600     Document Type: Article

References (27)

1. Jacobson JO, Polovich M, McNiff KK, et al: American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 36:651-658, 2009
2. Bonan B, Martelli N, Berhoune M, et al: The application of hazard analysis and critical control points and risk management in preparation of anti-cancer drugs. Int J Qual Health Care 21:44-50, 2009
3. Institute for Safe Medication Practices: Safe practices in pharmacy sterile compounding areas. http://www.ismp.org/newsletters/acutecare/articles/ 20110602.asp
4. Ranchon F, Salles G, Spath HM, et al: Chemotherapeutic errors in hospitalized cancer patients: Attributable damage and extra costs. BMC Cancer 11:478, 2011
5. Connor TH, DeBord DG, Pretty JR, et al: Evaluation of antineoplastic drug exposure of health care workers at three university-based US cancer centers. J Occup Environ Med 52:1019-1027, 2010
6. McDiarmid MA, Oliver MS, Roth TS, et al: Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med 52:1028-1034, 2010
7. Chaffee BW, Armitstead JA, Benjamin BE, et al: Guidelines for the safe handling of hazardous drugs: Consensus recommendations. Am J Health Syst Pharm 67:1545-1546, 2010
8. Davis J, McLauchlan R, Connor TH: Exposure to hazardous drugs in Healthcare: An issue that will not go away. J Oncol Pharm Pract 17:9-13, 2011
9. Falck K, Grhn P, Sorsa M, et al: Mutagenicity in urine of nurses handling cytostatic drugs. Lancet 313:1250-1251, 1979
10. Morimoto T, Gandhi TK, Seger AC, et al: Adverse drug events and medication errors: Detection and classification methods. Qual Saf Health Care 13:306-14, 2004
11. Bates DW: Preventing medication errors: A summary. Am J Health Syst Pharm 64:S3-S9, 2007 (suppl 9)
12. ASHP Council on Professional Affairs: ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm 59:1648-1668, 2002
13. Sessink PJ, Bos RP: Drugs hazardous to healthcare workers: Evaluation of methods for monitoring occupational exposure to cytostatic drugs. Drug Saf 210:347-359, 1999
14. Summerhayes M: The impact of workload changes and staff availability on IV chemotherapy services. J Onc Pharm Pract 9:123-128, 2003
15. Harrison MI, Koppel R, Bar-Lev S: Unintended consequences of information technologies in health care: An interactive sociotechnical analysis. J Am Med Inform Assoc 14:542-549, 2007
16. Flynn EA, Pearson RE, Barker KN: Observational study of accuracy in compounding IV admixtures at 5 hospitals. Am J Health Syst Pharm 54:904-912, 1997
17. Allan EL, Barker KN: Fundamentals of medication error research. Am J Hosp Pharm 47:555-571, 1990
18. Rothschild JM, Churchill W, Erickson A, et al: Medication errors recovered by emergency department pharmacists. Ann Emerg Med 55:513-521, 2010
19. Rothschild JM, Bartel S, Flynn EA, et al: An observational study of outpatient chemotherapy safety. J Gen Intern Med 16:215, 2001 (abstr; suppl 1)
20. Barker KN, Flynn EA, Pepper GA: Observation method of detecting medication errors. Am J Health Syst Pharm 59:2314-2316, 2002
21. Bates DW, Cullen DJ, Laird N, et al: Incidence of adverse drug events and potential adverse drug events. JAMA 274:29-34, 1995
22. Lecordier J, Heluin Y, Plivard C, et al: Safety in the preparation of cytotoxic drugs: How to integrate gravimetric control in the quality assurance policy? Biomed Pharmacother 65:17-21, 2010
23. Chapter 795: Pharmacy compounding-Physical tests, in United States Pharmacopeia (ed 27), Rockville, MD, United States Pharmacopeial Convention, 2003, p 2348
24. Fox BI, Felkey BG: Automated intravenous preparation: Robots for the pharmacy. Hosp Pharm 44:255-257, 2009
25. Rothschild JM, Keohane CA, Cook EF, et al: A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med 33:533-540, 2005
26. S.E.A. Medical Systems: IV check. http://www.seamedical.com/?pg- products&sl-iv-check
27. Fasola G, Aita M, Marini L, et al: Drug waste minimization and cost-containment in medical oncology. BMC Health Serv Res 8:70, 2008